UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Bio-optimized Curcuma longa extract is efficient on knee osteoarthritis pain: a double-blind multicenter randomized placebo controlled three-arm study

Arthritis research & therapy, 2019-07, Vol.21 (1), p.179-179, Article 179

2019

Volltextzugriff (PDF)

Treatment recommendations for psoriatic arthritis

Annals of the Rheumatic Diseases, 2009-09, Vol.68 (9), p.1387-1394

2009

Volltextzugriff (PDF)

The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal

Annals of the rheumatic diseases, 2009-06, Vol.68 (6), p.770-776

2009

Volltextzugriff (PDF)

Development and validation of a screening tool for SPondyloArthritis Screening in Sub-Saharan Africa: SpASSS questionnaire

BMC medical research methodology, 2023-06, Vol.23 (1), p.145-145, Article 145

2023

Volltextzugriff (PDF)

Early treatment of psoriatic arthritis is associated with improved patient-reported outcomes: findings from the etanercept PRESTA trial

Clinical and experimental rheumatology, 2015-01, Vol.33 (1), p.11

2015

Volltextzugriff (PDF)

Limited association between scalp psoriasis and psoriatic arthritis severity and treatment response

Clinical and experimental rheumatology, 2017-01, Vol.35 (1), p.141

2017

Volltextzugriff (PDF)

EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update

Annals of the rheumatic diseases, 2017-01, Vol.76 (1), p.17-28

2017

Volltextzugriff (PDF)

Which spinal lesions are associated with new bone formation in patients with ankylosing spondylitis treated with anti-TNF agents? A long-term observational study using MRI and conventional radiography

Annals of the rheumatic diseases, 2014-10, Vol.73 (10), p.1819-1825

2014

Volltextzugriff (PDF)

European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies

Annals of the Rheumatic Diseases, 2012-01, Vol.71 (1), p.4-12

2012

Volltextzugriff (PDF)

Progress in spondylarthritis. Mechanisms of new bone formation in spondyloarthritis

Arthritis research & therapy, 2009-01, Vol.11 (2), p.221-221

2009

Volltextzugriff (PDF)

OP0311 Notable evolutions in the characteristics of psoriatic arthritis clinical trials populations in the era of biological treatments

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.202

2018

Volltextzugriff (PDF)

The effectiveness of exercise and physical activity programs on fatigue and sleep in people with arthritis – A systematic review with meta-analysis

Sleep medicine reviews, 2023-10, Vol.71, p.101832-101832, Article 101832

2023

Volltextzugriff (PDF)

Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial

Annals of the rheumatic diseases, 2005-08, Vol.64 (8), p.1150-1157

2005

Volltextzugriff (PDF)

Effectiveness of different combinations of DMARDs and glucocorticoid bridging in early rheumatoid arthritis: two-year results of CareRA

Rheumatology (Oxford, England), 2019-12, Vol.58 (12), p.2284-2294

2019

Volltextzugriff (PDF)

THU0711-HPR Widespread pain in axial spondyloarthritis: clinical importance and gender differences

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.1784

2018

Volltextzugriff (PDF)

Arthritis and B-cell lymphoma: is the most obvious diagnosis the right one?

Scandinavian journal of rheumatology, 2022-07, Vol.51 (4), p.330-332

2022

Volltextzugriff (PDF)

Long-term efficacy of infliximab treatment for AA-amyloidosis secondary to chronic inflammatory arthritis

Annals of the rheumatic diseases, 2009-05, Vol.68 (5), p.759-761

2009

Volltextzugriff (PDF)

POS0907 EFFECT OF UPADACITINIB ON REDUCING PAIN IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS AND INADEQUATE RESPONSE TO NONSTEROIDAL ANTI-INFLAMMATORY DRUGS

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.712-713

2021

Volltextzugriff (PDF)

AB0530 EFFECT OF SKIN SYMPTOMS ON DISEASE IMPACT IN PATIENTS WITH PSORIATIC ARTHRITIS RECEIVING THE IL-12/23 INHIBITOR USTEKINUMAB OR TNF INHIBITORS IN THE REAL-WORLD PSABIO STUDY

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.1295-1296

2021

Volltextzugriff (PDF)

POS1046 IMPROVEMENTS IN PATIENT-REPORTED IMPACT OF PSORIATIC ARTHRITIS WITH IL-12/23 (USTEKINUMAB) OR TUMOUR NECROSIS FACTOR INHIBITORS: 1-YEAR DATA FROM THE LARGE, REAL-WORLD PsABIO STUDY

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.799-800

2021

Volltextzugriff (PDF)

OP0232 FEMALE VERSUS MALE BURDEN OF PSORIATIC ARTHRITIS IS HIGHER AND TREATMENT PERSISTENCE SHORTER AFTER USTEKINUMAB OR TUMOUR NECROSIS FACTOR INHIBITOR TREATMENT: 1-YEAR DATA FROM THE PSABIO STUDY

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.142-143

2021

Volltextzugriff (PDF)

Osteoporosis in rheumatoid arthritis and ankylosing spondylitis

Clinical and experimental rheumatology, 2009-07, Vol.27 (4 Suppl 55), p.S62

2009

Volltextzugriff (PDF)

AB0584 Safety and efficacy of etanercept in patients with active psoriatic arthritis with peripheral involvement in belgium: 66 months follow-up

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A968-A968

2013

Volltextzugriff (PDF)

OP0164 Long-term TNF blockade induces joint repair in psoriatic arthritis

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.109-110

2013

Volltextzugriff (PDF)

Corrélation entre amélioration des résultats rapportés par le patient (PRO) et mesures strictes de l’activité de la maladie chez des patients atteints de rhumatisme psoriasique et traités par upadacitinib versus placebo ou adalimumab

Revue du rhumatisme (Ed. française : 1993), 2021-12, Vol.88, p.A207-A208

2021

Volltextzugriff (PDF)

1 – 25 von 179

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(165)
Mit Volltextzugriff
(96)

Publikationsform

Sprache

Englisch
(169)
Französisch
(11)

Erscheinungsjahr

n.n

Thema

Science & Technology
(75)
Life Sciences & Biomedicine
(74)
Rheumatology
(73)
Humans
(66)
Male
(52)
Female
(49)
Middle Aged
(44)
Adult
(42)
Biological And Medical Sciences
(35)
Medical Sciences
(35)
Psoriatic Arthritis
(34)
Arthritis
(32)
Ankylosing Spondylitis
(31)
Patients
(30)
Diseases Of The Osteoarticular System
(27)
Inflammatory Joint Diseases
(26)
Aged
(25)
Severity Of Illness Index
(21)
Rheumatoid Arthritis
(19)
Antirheumatic Agents - Therapeutic Use
(18)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Bio-optimized Curcuma longa extract is efficient on knee osteoarthritis pain: a double-blind multicenter randomized placebo controlled three-arm study

Treatment recommendations for psoriatic arthritis

The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal

Development and validation of a screening tool for SPondyloArthritis Screening in Sub-Saharan Africa: SpASSS questionnaire

Early treatment of psoriatic arthritis is associated with improved patient-reported outcomes: findings from the etanercept PRESTA trial

Limited association between scalp psoriasis and psoriatic arthritis severity and treatment response

EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update

Which spinal lesions are associated with new bone formation in patients with ankylosing spondylitis treated with anti-TNF agents? A long-term observational study using MRI and conventional radiography

European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies

Progress in spondylarthritis. Mechanisms of new bone formation in spondyloarthritis

OP0311 Notable evolutions in the characteristics of psoriatic arthritis clinical trials populations in the era of biological treatments

The effectiveness of exercise and physical activity programs on fatigue and sleep in people with arthritis – A systematic review with meta-analysis

Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial

Effectiveness of different combinations of DMARDs and glucocorticoid bridging in early rheumatoid arthritis: two-year results of CareRA

THU0711-HPR Widespread pain in axial spondyloarthritis: clinical importance and gender differences

Arthritis and B-cell lymphoma: is the most obvious diagnosis the right one?

Long-term efficacy of infliximab treatment for AA-amyloidosis secondary to chronic inflammatory arthritis

POS0907 EFFECT OF UPADACITINIB ON REDUCING PAIN IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS AND INADEQUATE RESPONSE TO NONSTEROIDAL ANTI-INFLAMMATORY DRUGS

AB0530 EFFECT OF SKIN SYMPTOMS ON DISEASE IMPACT IN PATIENTS WITH PSORIATIC ARTHRITIS RECEIVING THE IL-12/23 INHIBITOR USTEKINUMAB OR TNF INHIBITORS IN THE REAL-WORLD PSABIO STUDY

POS1046 IMPROVEMENTS IN PATIENT-REPORTED IMPACT OF PSORIATIC ARTHRITIS WITH IL-12/23 (USTEKINUMAB) OR TUMOUR NECROSIS FACTOR INHIBITORS: 1-YEAR DATA FROM THE LARGE, REAL-WORLD PsABIO STUDY

OP0232 FEMALE VERSUS MALE BURDEN OF PSORIATIC ARTHRITIS IS HIGHER AND TREATMENT PERSISTENCE SHORTER AFTER USTEKINUMAB OR TUMOUR NECROSIS FACTOR INHIBITOR TREATMENT: 1-YEAR DATA FROM THE PSABIO STUDY

Osteoporosis in rheumatoid arthritis and ankylosing spondylitis

AB0584 Safety and efficacy of etanercept in patients with active psoriatic arthritis with peripheral involvement in belgium: 66 months follow-up

OP0164 Long-term TNF blockade induces joint repair in psoriatic arthritis

Corrélation entre amélioration des résultats rapportés par le patient (PRO) et mesures strictes de l’activité de la maladie chez des patients atteints de rhumatisme psoriasique et traités par upadacitinib versus placebo ou adalimumab

Suchergebnisse filtern